1-4 of 4
Günter Krause
Close
Sort by
Journal Articles

BIM Regulation Is BTK Dependent and Can be Targeted By Entospletinib in Ibrutinib Refractory Mutants

Laura Beckmann, MD, Valeska Berg, PhD, Clarissa Dickhut, Gunter Krause, PhD, René Zahedi, PhD, Michael Hallek, Lukas P. Frenzel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1765.
https://doi.org/10.1182/blood-2019-127148
Published: 2019
Journal Articles

Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor

Nina Reinart, Phuong-Hien Nguyen, Jorge Boucas, Natascha Rosen, Hans-Michael Kvasnicka, Lukas Heukamp, Cornelia Rudolph, Vangica Ristovska, Tanja Velmans, Carolin Mueller, Katrin S. Reiners, Elke Pogge von Strandmann, Günter Krause, Manuel Montesinos-Rongen, Brigitte Schlegelberger, Marco Herling, Michael Hallek, Günter Fingerle-Rowson
Journal: Blood
Blood (2013) 121 (5): 812–821.
https://doi.org/10.1182/blood-2012-05-431452
Published: 2013
Includes: Supplemental data
Journal Articles

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Christian Philipp Pallasch, Michaela Patz, Yoon Jung Park, Susanne Hagist, Daniela Eggle, Rainer Claus, Svenja Debey-Pascher, Alexandra Schulz, Lukas P. Frenzel, Julia Claasen, Nadine Kutsch, Günter Krause, Christine Mayr, Andreas Rosenwald, Christoph Plass, Joachim L. Schultze, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2009) 114 (15): 3255–3264.
https://doi.org/10.1182/blood-2009-06-229898
Published: 2009
Includes: Supplemental data
Journal Articles

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgV H genes

Aditya Veldurthy, Michaela Patz, Susanne Hagist, Christian P. Pallasch, Clemens-Martin Wendtner, Michael Hallek, Günter Krause
Journal: Blood
Blood (2008) 112 (4): 1443–1452.
https://doi.org/10.1182/blood-2007-11-123984
Published: 2008
Includes: Supplemental data